Mar 13, 2023 / 04:00PM GMT
Scott Henry - ROTH MKM Partners - Analyst
Okay, thank you and good morning. My name is Scott Henry, healthcare analyst at ROTH MKM Partners. Thank you for joining this fireside chat, which will also be webcast. Our focus company is Fortress Biotech; ticker, FBIO; market cap, approximately $100 million. Participating from the company is Lindsay Rosenwald, CEO and Chairman. Let's get started.
Lindsay, thank you for coming to the ROTH Conference. Could you take a couple of minutes to tell us about Fortress? After that, we'll open it up for discussion. We have about 25 minutes. (Conference Instructions) Thank you. Lindsay?
Lindsay Rosenwald - Fortress Biotech, Inc. - Chairman, President & CEO
Sure. So Fortress is certainly a different kind of life science company. I've been in the business a long time. I know it's an incredibly risky business, and I'm incredibly risk averse. So it's -- when I took over what became Fortress, I decided to build something that we could focus on risk aversion, and at the same time, focus on potential great growth and
Fortress Biotech Inc at ROTH Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot